New AI models and digital twins create virtual cells to speed up medicine creation

Scientists have developed virtual cells using four-dimensional artificial intelligence models and digital twins to help speed up the process of discovering new medicines. These computer-based models mimic real biological cells in motion over time, allowing researchers to test how potential drugs might work without needing to perform every single experiment in a physical laboratory first. Drug discovery normally takes many years and costs a large amount of money, but this new technology aims to cut down those delays by predicting cellular reactions much faster. By using digital copies of cells, teams can run thousands of simulations to see which chemical compounds show promise and which ones fail. This approach bridges the gap between raw data and real-world biology, giving scientists a clearer picture of how diseases affect the human body at a microscopic level. While the research is still developing, experts hope that these virtual models will soon become a standard tool in pharmaceutical laboratories across the world to bring safe and effective treatments to patients much sooner.